NCT03419689Recruiting
Study Looking at Biomarkers in Ovarian Cancer
Biomarker Discovery Project in High Grade Serous Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 510 (estimated)
- First submitted
- 8 Aug 2017
- Start date
- 8 Jan 2018
- Primary completion date
- 8 Jun 2028
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Ovarian cancer
- NCT number
- NCT03419689
What you commit to
- Study type: Interventional
- Planned participants: 510
- From 8 Jan 2018 to the primary completion date, 8 Jun 2028
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
Other
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
Who the study is looking for
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
- Willing to undergo blood or fluid collection and tumour biopsy
- Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
- Archival tissue must be available for patients that are enrolled at the time of progression.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Victoria Regional Health Centre Coordinator of this site? Confirm its status | Barrie | Canada | Recruiting |
| Juravinski Cancer Centre Coordinator of this site? Confirm its status | Hamilton | Canada | Active, not recruiting |
| Kingston Health Sciences Centre Coordinator of this site? Confirm its status | Kingston | Canada | Recruiting |
| London Health Sciences Centre Coordinator of this site? Confirm its status | London | Canada | Recruiting |
| The Ottawa Hospital Cancer Centre Coordinator of this site? Confirm its status | Ottawa | Canada | Recruiting |
| Sunnybrook Health Sciences Centre Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
| Princess Margaret Cancer Centre Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.